Sep 14, 2020 / 04:45PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
Good afternoon, everyone. Thanks for joining us today on the first day of our healthcare conference here. Before we kick things off, there's a quick disclaimer I need to read. Please note that the webcast is for Morgan Stanley's clients and appropriate employees only. The webcast is not meant for members of the press. And if you're with the press, please disconnect and reach out separately. For important disclosures, please see morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales rep.
Questions and Answers:
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity AnalystSo with that, thanks for joining us, Brad. It's a pleasure to have you and NanoString with us today. So maybe to kick things off, I mean, because people are pretty familiar with the story. So I'll spare you the softball. But just in terms of GeoMx, on the second quarter call, you called the launch of the NGS readout capability is the most important
Trustpilot
